community download

"Clinical Development of ceftazidime-avibactam...Navigating an evolving regulatory environment"

information we require

please check before submitting



Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Clinical Development of ceftazidime-avibactam...Navigating an evolving regulatory environment

David Melnick, M.D., Vice President Clinical Development , Anti-Infectives at Allergan Pharmaceuticals  joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss 'Clinical development of ceftzadime-avibactam...Navigating an evolving regulatory environment.'
 
In this presentation, learn about some of the effects of the changing regulatory environment on the clinical development of ceftazidime-avibactam .
 
Download the presentation to understand more about:
  • Avycaz
  • Carbapenem-resistant Enterobacteriaceae (CRE)
  • Well-defined PK/PD Targets

...and much more!

 

Get your copy here!


To learn more about navigating an evolving regulatory environment , join us at   World Anti-Microbial Resistance Congress USA 2016 held  September 8-9  in  Washington, DC .